Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Marrone Bio Innovations

Request full access

Pesticide company developing natural products for weed, pest, and plant disease management

Davis, United StatesFounded 2006Food

About Marrone Bio Innovations

Marrone Bio Innovations (MBI) was an agricultural technology company focused on the discovery, development, and sale of biologically-based products for pest management and plant health. The company was founded in 2006 by Dr. Pamela Marrone, a serial entrepreneur in the agricultural biotechnology space. Her journey in this field began with a childhood fascination with entomology after seeing caterpillar infestations destroy trees. This passion led her to earn a B.S. in Entomology from Cornell University and a Ph.D. in the same field from North Carolina State University. Before founding MBI, Dr. Marrone started her career at Monsanto, founded Entotech Inc. for Novo Nordisk, and established AgraQuest, which was later acquired by Bayer Crop Science.

MBI targeted the agricultural sector, serving growers of specialty crops like fruits, nuts, and vegetables, as well as row crops and the turf and ornamental markets. The company's business model revolved around creating environmentally responsible alternatives to conventional chemical pesticides. Revenue was generated through the sale of its portfolio of proprietary products. The company's research and development program screened thousands of naturally occurring microorganisms and plant extracts to create its solutions, which were supported by a portfolio of over 500 issued and pending patents.

The product lineup included biofungicides, bioinsecticides, and bionematicides. Key products included REGALIA®, a plant extract-based biofungicide that promotes plant health, and GRANDEVO® and VENERATE®, which are microbial-based insecticides. Another product, Zequanox®, was developed to control invasive zebra and quagga mussels in water systems. These products offered growers a way to manage pests and diseases, potentially increase yields, and reduce the environmental load of chemical residues.

A significant milestone for MBI was its initial public offering on the NASDAQ stock exchange (as MBII) on August 2, 2013. In 2019, the company expanded its offerings by acquiring Pro Farm Technologies OY, a Finnish company specializing in nutrient and biostimulant products for seed and foliar treatments. However, the company also faced challenges, including an accounting scandal in 2016 that led to a restatement of financial results and a penalty. Dr. Marrone retired as CEO in 2020. In July 2022, Marrone Bio Innovations was acquired by the Argentinian firm Bioceres Crop Solutions in an all-stock transaction valued at approximately $236 million, combining the two companies' portfolios to create a larger entity in sustainable agricultural solutions. Following the merger, MBI was set to continue its operations as a wholly-owned subsidiary of Bioceres under the name ProFarm.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2013
Employees
154
Open positions
1
Dealroom signal
59.3/100
Industry
Food
Sub-industry
AgriTech
Sector
Biotechnology, Non-Invasive medical devices and treatments, Biotech and Pharma, Biotechnology in Food, Hard Tech, DT and LS, science-based
Client focus
B2B
Investment activity
1 company, latest Aug 2019
Capital deployed
—
Preferred round
ACQUISITION

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Mar 2022 $236M $236M Bioceres Crop Solutions ↗
POST IPO EQUITYOther financing Feb 2018 $30M — Ospraie Ag Science —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Marrone Bio Innovations website traffic

Latest recorded traffic for Marrone Bio Innovations is 560 monthly website visits, up 93.1% over the last three months. Marrone Bio Innovations's team grew 0% over the past year.

Latest monthly visits560 3-month web change+93.1% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Marrone Bio Innovations in the Davis ecosystem

Live from Dealroom

The Marrone Bio Innovations office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • Clean Pacific Ventures
  • Saffron Hill Ventures
  • Calvert Research and Management
  • Valley Oak Investments
  • Wavepoint Ventures
  • One Earth Capital
  • Stuart Mill Venture Partners

Series B and later5 investors entered at this stage

  • Syngenta Ventures
  • The Contrarian Group
  • Mitsui Global Investment
  • Point Financial
  • Ospraie Ag Science

Other known investors6 additional known investors

  • Bioceres Crop Solutions
  • Checkmate Capital
  • Checkmate Capital Group
  • Syngenta Group Ventures
  • US Department of Agriculture
  • Van Herk Investments
Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Davis HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Marrone Bio Innovations on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Marrone Bio Innovations’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.